Here, cyclophilin A (CypA) is identified as a critical mediator of cisplatin (DDP)/paclitaxel (DTX) resistance in NSCLC by suppressing ferroptosis, an iron‐dependent form of regulated cell death. The gene discussed is PPIA; the disease is non-small cell lung carcinoma.